Cite
Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial.
MLA
Kondo, Toru, et al. “Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial.” Journal of the American College of Cardiology (JACC), vol. 83, no. 20, May 2024, pp. 1973–86. EBSCOhost, https://doi.org/10.1016/j.jacc.2024.03.385.
APA
Kondo, T., Mogensen, U. M., Talebi, A., Gasparyan, S. B., Campbell, R. T., Docherty, K. F., de Boer, R. A., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Sabatine, M. S., Bengtsson, O., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Jhund, P. S., & McMurray, J. J. V. (2024). Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial. Journal of the American College of Cardiology (JACC), 83(20), 1973–1986. https://doi.org/10.1016/j.jacc.2024.03.385
Chicago
Kondo, Toru, Ulrik M. Mogensen, Atefeh Talebi, Samvel B. Gasparyan, Ross T. Campbell, Kieran F. Docherty, Rudolf A. de Boer, et al. 2024. “Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial.” Journal of the American College of Cardiology (JACC) 83 (20): 1973–86. doi:10.1016/j.jacc.2024.03.385.